This study is looking at how well an injectable gel called Obagi® Saypha® MagIQ™ works to improve mild-to-moderate signs of facial aging, such as volume loss, fine lines, and loose skin. The gel is made of hyaluronic acid (HA), a substance naturally found in the body. Researchers will give up to two treatments with the gel and then check for improvements in your appearance at 14 and 60 days after the first treatment. You may be able to join if you are between 30 and 75 years old and have mild-to-moderate facial aging. The study plans to enroll 100 people.

Study design

This is an interventional study planning to enroll 100 participants. It is designed to assess the real-world effectiveness of the injectable gel.

What's involved

You would receive up to two treatments with the gel and have follow-up visits at day 14 and day 60, which include photography and assessments.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 60 days after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.